Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Arch Psychiatry Clin Neurosci ; 271(7): 1331-1341, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33733300

ABSTRACT

Adverse Childhood Experiences (ACE) are a well-known risk-factor for depression. Additionally, (high-sensitive) C-reactive Protein (hsCRP) is elevated in subgroups of depressed patients and high following ACE. In this context the literature considers hsCRP and ACE to be associated with treatment resistant depression. With the data being heterogenous, this study aimed to explore the associations of ACE, hsCRP levels and response to antidepressant treatment in uni- and bipolar depression. N = 76 patients diagnosed with uni- or bipolar depression and N = 53 healthy controls were included. Treatment was over 6 weeks in an inpatient psychiatric setting within an observatory study design. Depressive symptoms were assessed by the Montgomery-Asberg Depression Rating Scale (MADRS), ACE were assessed by the Childhood Trauma Questionnaire (CTQ); the body-mass-index (BMI) and hsCRP were measured. HsCRP levels did not differ between the study population and the healthy controls. While the depressive symptoms decreased, the hsCRP levels increased. Sexual abuse was associated with significant higher and emotional abuse with lower levels of hsCRP after 6 weeks. The baseline hsCRP levels and the ACE subgroups did not show significant associations with the treatment response in unipolar depressed patients. The long-lasting effects of specific forms of ACE may have relevant impact on inflammation, supporting hsCRP to be a suitable biomarker. With ACE and hsCRP not showing any significant associations with treatment response in the unipolar depressed subgroup, a more differentiate research concerning biomarkers and treatment regimens is needed when talking about treatment response.


Subject(s)
Adverse Childhood Experiences , Antidepressive Agents , Bipolar Disorder , C-Reactive Protein , Depressive Disorder , Antidepressive Agents/therapeutic use , Biomarkers/blood , Bipolar Disorder/blood , Bipolar Disorder/drug therapy , C-Reactive Protein/analysis , Case-Control Studies , Depressive Disorder/blood , Depressive Disorder/drug therapy , Depressive Disorder, Treatment-Resistant , Humans , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...